ELI-002
Elicio Therapeutics
['rectal', 'colorectal', 'amplify-201', 'eli-002 ', 'pancreatic']
amplify-201, a first-in-human safety and efficacy trial of adjuvant eli-002 2p #immunotherapy for patients with high-relapse risk with #kras g12d- or g12r-mutated pancreatic and colorectal cancer. #asco23 #asco2023 #clinicaltrials #news 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News